Skip to content

Seenthil choornam

A clinical study to evaluate the effectiveness of siddha Herbal Formulation Seenthil Choornam IN THE treatment OF erigunmam(acid peptic disease) - SC

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067586
Enrollment
30
Registered
2024-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K279- Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation

Interventions

Intervention1: Seenthil chooranam: Seenthil chooranam is indicated for gunmam and advised to take for 48 days with honey Control Intervention1: Nil: Nil

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient who are having symptoms of Eri Gunmam burning sensation in epigastric region colic pain increased salivation flatulence Burping headache diarrhea Any of 3 symptoms for the duration of 3 months by GSRS scale Patient who are willing to give blood samples before & after treatment

Exclusion criteria

Exclusion criteria: Gastric CA Liver disorders Cardiac disease Uncontrolled diabetes Pregnancy Lactation

Design outcomes

Primary

MeasureTime frame
Primary outcome is assessed by comparing the reduction of clinical symptoms before and after treatment by using Gastrointestinal symptoms rating scale GSRSTimepoint: 12 MONTHS

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDrHVetha merlin kumari

National Institute of Siddha

dr.vetha@gmail.com9894782366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026